Manufacturing Chemist Manufacturing Chemist
  • Home
  • Ingredients
  • Analysis
  • Manufacturing
  • Finance
  • Events
  • Directory
  • Regulatory
  • Drug Delivery
  • Research & Development
  • Sustainability

Career Opportunities: Sr Scientist, On Market Products (5942)

11-May-2020
Recruitment | Research & Development | Pharmaceutical

Xellia Pharmaceuticals is owned by Novo Holding A/S and is a specialty pharmaceutical company leading in the development, manufacture and supply of anti-infective treatments

Career Opportunities: Sr Scientist, On Market Products (5942)
Sign up for your free email newsletter

Responsible for product stewardship of on market products manufactured at the Cleveland facility. Serve as subject matter expert for on market products for product/process improvements, trending, and technical issues. Support product complaints as necessary.

To find out more about the role and to apply, click here

Companies

  • Xellia Pharmaceuticals

Related Content

Xellia Pharmaceuticals expands approved doses of VANCO READYTM
Xellia Pharmaceuticals expands approved doses of VANCO READYTM
Career Opportunities: Automation Engineer (7243)
Career Opportunities: Automation Engineer (7243)
Career Opportunities: Global Packaging Manager, Sterile Products (5677)
Career Opportunities: Global Packaging Manager, Sterile Products (5677)
Career Opportunities: Senior Logistics and Process Engineer (6982)
Career Opportunities: Senior Logistics and Process Engineer (6982)
Career Opportunities: Compliance Quality Assurance Specialist (5667)
Career Opportunities: Compliance Quality Assurance Specialist (5667)
Xellia divests North Carolina production facilities to Sagent Pharmaceuticals
Xellia divests North Carolina production facilities to Sagent Pharmaceuticals
Xellia Pharmaceuticals appoints Matthew Anderson as CFO
Xellia Pharmaceuticals appoints Matthew Anderson as CFO
Xellia Pharmaceuticals expands with US$25m investment in Copenhagen
Xellia Pharmaceuticals expands with US$25m investment in Copenhagen
Xellia Pharmaceuticals Commences Packaging and Distribution Operations at Cleveland Site after Successful FDA Inspection
Xellia Pharmaceuticals Commences Packaging and Distribution Operations at Cleveland Site after Successful FDA Inspection
Xellia opens new API R and D centre in Oslo
Xellia opens new API R and D centre in Oslo
Actavis, DSM Biologics and Dr. Reddy\'s to speak at Pharma Integrates 2013
Actavis, DSM Biologics and Dr. Reddy\'s to speak at Pharma Integrates 2013
Xellia enters 4-year antibiotics collaboration
Xellia enters 4-year antibiotics collaboration
  • Advertise Subscribe
  • Terms & Conditions
  • Privacy Policy
  • Contact us at info@hpcimedia.com
Twitter LinkedIn RSS newsfeed
© HPCi Media Limited | Registered in England No. 6716035 | VAT GB 939828072 | a Claverley Group company